SRBT — Shanrong Biotechnology Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Shanrong Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 July 31st | 2008 July 31st | 2008 December 31st | 2009 December 31st | |
|---|---|---|---|---|
| Period Length: | 8 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.046 | 0.001 | 0.062 | 0.031 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | — | — | 0.145 | 0.097 |
| Total Inventory | ||||
| Total Current Assets | 0.046 | 0.001 | 0.307 | 0.128 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.006 | 0 | 0.098 | 0.063 |
| Total Assets | 0.052 | 0.001 | 0.405 | 0.191 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Current Liabilities | 0.03 | 0.019 | 4.01 | 4.05 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.03 | 0.019 | 4.06 | 4.17 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 0.022 | -0.018 | -3.65 | -3.98 |
| Total Liabilities & Shareholders' Equity | 0.052 | 0.001 | 0.405 | 0.191 |
| Total Common Shares Outstanding |